Xianwei Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xianwei Zhu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Hiroaki Shinohara
Faculty of Engineering, Academic Assembly, University of Toyama
3 shared publications Aimin Zhang
Department of Urologic Surgery, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xi'an-Xianyang New Ecomic Zone, Xi'an City, Shaanxi Province, China
2 shared publicationsHongyan Qu
Department of Acupuncture and Moxibustion, Shaanxi University of Chinese Medicine, Xi'an-Xianyang New Ecomic Zone, Xianyang City, Shaanxi Province, China
2 shared publicationsJing Zhou
College of Public Hygiene, Shaanxi University of Chinese Medicine, Xi'an-Xianyang New Ecomic Zone, Xianyang, Shaanxi Province, China
2 shared publicationsLu Bai
Department of English, Shaanxi University of Chinese Medicine, Xi'an-Xianyang New Ecomic Zone, Xi'an, Shaanxi Province, China
2 shared publicationsTakahiro Hohsaka
School of Materials Science, Japan Advanced Institute of Science and Technology, 1-1 Asahidai, Nomi, Ishikawa, 923-1292, Japan
2 shared publications
Latest Publications
- 19 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 797, 153171
Tanshinone IIA accelerates diabetic wound healing via suppression of macrophage NLRP3 inflammasome activity
- 19 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 797, 153171
Tanshinone IIA accelerates diabetic wound healing via suppression of macrophage NLRP3 inflammasome activity
- 8 October 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 685, 126237
Dual-drug thermosensitive hydrogel-based microneedles for synchronized transdermal delivery of paeoniflorin and glycyrrhizic acid
- 8 October 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 685, 126237
Dual-drug thermosensitive hydrogel-based microneedles for synchronized transdermal delivery of paeoniflorin and glycyrrhizic acid
- 1 June 2017
- Published by SAGE Publications in Acupuncture in Medicine
- Vol. 35 (3) , 216-223
Effects of Electroacupuncture at St25 and Bl25 in a Sennae -induced rat model of diarrhoea-predominant irritable bowel syndrome
Background Electroacupuncture (EA) may have a role in the treatment of diarrhoea symptoms. Serotonin (5-hydroxytryptamine, 5-HT) is an important neurotransmitter and paracrine signalling molecule in the gastrointestinal (GI) tract, which initiates peristaltic, secretory, vasodilatory, vagal and nociceptive reflexes. In addition, according to the results of our previous report, EA stimulation mediates GI peristalsis by increasing expression of 5-HT and tryptophan hydroxylase (TPH). Aim To investigate the effect of EA at acupuncture points ST25 and BL25 in a rat model of diarrhoea. Methods A diarrhoea-predominant irritable bowel syndrome (IBS-D) model was induced by Folium Sennae in 24 rats, which remained untreated (n=6) or received EA at ST25 (n=6), BL25 (n=6) or the combination of ST25 and BL25 (n=6). A control group of healthy rats was also included (n=6). After treatment, changes in loose stool and small intestine transit rates, enterochromaffin (EC) cell number, expression of TPH, and faecal/colonic 5-HT contents were measured. Results Loose stool and small intestine transit rates, EC cell numbers, colonic TPH expression and faecal/colonic 5-HT content of IBS-D rats were significantly increased relative to controls (pConclusions EA at ST25 and/or BL25 had a positive effect on objective markers of diarrhoea in a IBS-D rat model and induced changes in EC cell number, colonic TPH and 5-HT contents. The effects of EA stimulation at ST25/BL25 on IBS-D rats may be mediated by excitation of sympathetic nerves.
- 1 June 2017
- Published by SAGE Publications in Acupuncture in Medicine
- Vol. 35 (3) , 216-223
Effects of Electroacupuncture at St25 and Bl25 in a Sennae -induced rat model of diarrhoea-predominant irritable bowel syndrome
Background Electroacupuncture (EA) may have a role in the treatment of diarrhoea symptoms. Serotonin (5-hydroxytryptamine, 5-HT) is an important neurotransmitter and paracrine signalling molecule in the gastrointestinal (GI) tract, which initiates peristaltic, secretory, vasodilatory, vagal and nociceptive reflexes. In addition, according to the results of our previous report, EA stimulation mediates GI peristalsis by increasing expression of 5-HT and tryptophan hydroxylase (TPH). Aim To investigate the effect of EA at acupuncture points ST25 and BL25 in a rat model of diarrhoea. Methods A diarrhoea-predominant irritable bowel syndrome (IBS-D) model was induced by Folium Sennae in 24 rats, which remained untreated (n=6) or received EA at ST25 (n=6), BL25 (n=6) or the combination of ST25 and BL25 (n=6). A control group of healthy rats was also included (n=6). After treatment, changes in loose stool and small intestine transit rates, enterochromaffin (EC) cell number, expression of TPH, and faecal/colonic 5-HT contents were measured. Results Loose stool and small intestine transit rates, EC cell numbers, colonic TPH expression and faecal/colonic 5-HT content of IBS-D rats were significantly increased relative to controls (pConclusions EA at ST25 and/or BL25 had a positive effect on objective markers of diarrhoea in a IBS-D rat model and induced changes in EC cell number, colonic TPH and 5-HT contents. The effects of EA stimulation at ST25/BL25 on IBS-D rats may be mediated by excitation of sympathetic nerves.
- Open Access
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 8547257
The Anti‐Inflammatory Effect of Guchangzhixie‐Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model
Ulcerative colitis (UC) is one of the major types of inflammatory bowel diseases (IBD). Abnormal colonic enterochromaffin (EC) cell hyperplasia and serotonin availability have been described in UC. Guchangzhixie‐pill (GCZX‐pill), a Chinese herbal formula composed of six herbs, is modified based on a traditional formula (Jiechangyan‐pill) for inflammatory and ulcerative gastrointestinal disorders. This study aims to investigate the anti‐inflammatory effect and the underlying mechanisms of GCZX‐pill on trinitrobenzene sulfonic acid‐ (TNBS‐) induced UC in rats. After orally administrating a GCZX‐pill to UC rats for 14 days, the results of the inflammation evaluation, such as disease activity index (DAI), macroscopic score (MS), myeloperoxidase (MPO) activity, and other methods, suggested that the GCZX‐pill showed remarkable anti‐inflammatory results in UC rats. In addition, the abnormal EC cell numbers, colonic tryptophan hydroxylase (TPH) expression, and serotonin (5‐HT) contents in TNBS‐induced UC rats were significantly reduced by the GCZX‐pill. This data demonstrates that the GCZX‐pill can attenuate the inflammation in UC rats and the anti‐inflammatory effect of the GCZX‐pill may be medicated by reducing colonic EC cell hyperplasia and 5‐HT availability.
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 8547257
Open AccessThe Anti‐Inflammatory Effect of Guchangzhixie‐Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model
Ulcerative colitis (UC) is one of the major types of inflammatory bowel diseases (IBD). Abnormal colonic enterochromaffin (EC) cell hyperplasia and serotonin availability have been described in UC. Guchangzhixie‐pill (GCZX‐pill), a Chinese herbal formula composed of six herbs, is modified based on a traditional formula (Jiechangyan‐pill) for inflammatory and ulcerative gastrointestinal disorders. This study aims to investigate the anti‐inflammatory effect and the underlying mechanisms of GCZX‐pill on trinitrobenzene sulfonic acid‐ (TNBS‐) induced UC in rats. After orally administrating a GCZX‐pill to UC rats for 14 days, the results of the inflammation evaluation, such as disease activity index (DAI), macroscopic score (MS), myeloperoxidase (MPO) activity, and other methods, suggested that the GCZX‐pill showed remarkable anti‐inflammatory results in UC rats. In addition, the abnormal EC cell numbers, colonic tryptophan hydroxylase (TPH) expression, and serotonin (5‐HT) contents in TNBS‐induced UC rats were significantly reduced by the GCZX‐pill. This data demonstrates that the GCZX‐pill can attenuate the inflammation in UC rats and the anti‐inflammatory effect of the GCZX‐pill may be medicated by reducing colonic EC cell hyperplasia and 5‐HT availability.
- Open Access
- 1 June 2016
- Published by SAGE Publications in Acupuncture in Medicine
- Vol. 34 (3) , 194-200
The Effect and Mechanism of Electroacupuncture at Li11 and St37 on Constipation in a Rat Model
Background Electroacupuncture (EA) is used clinically for the treatment of constipation. Serotonin (5-hydroxytryptamine, 5-HT) plays an important role in colonic motility; however it is unknown whether alterations in colonic 5-HT are associated with EA. In this study, the effect and mechanism of EA at acupuncture points LI11 and ST37 were examined using a cold saline-induced rat model of constipation. Methods A rat constipation model was induced by cold saline gavage in 24 Sprague-Dawley rats. A further six rats were included as a Control group. The constipated rats were divided into four groups (n=6 each): a Constipation group that remained untreated; a Constipation+LI11 group that received EA at LI11; a Constipation+ST37 groups that received EA at ST37; and a Constipation+LI11+ST37 group that received EA at both LI11 and ST37. After EA treatment, faecal water content, defaecation frequency, and gastrointestinal (GI) transit were measured, as well as the expression of tryptophan hydroxylase (TPH) in colonic tissues (by Western blot analysis) and 5-HT in both faeces and colonic tissues (by ELISA). Results All three EA-treated groups demonstrated significant improvements in faecal water content, defaecation frequency and GI transit (pConclusions EA at LI11 and/or ST37 had a positive effect on objective markers of constipation in a rat model. In addition, EA increased 5-HT and TPH in the colonic tissues.
- 1 June 2016
- Published by SAGE Publications in Acupuncture in Medicine
- Vol. 34 (3) , 194-200
Open AccessThe Effect and Mechanism of Electroacupuncture at Li11 and St37 on Constipation in a Rat Model
Background Electroacupuncture (EA) is used clinically for the treatment of constipation. Serotonin (5-hydroxytryptamine, 5-HT) plays an important role in colonic motility; however it is unknown whether alterations in colonic 5-HT are associated with EA. In this study, the effect and mechanism of EA at acupuncture points LI11 and ST37 were examined using a cold saline-induced rat model of constipation. Methods A rat constipation model was induced by cold saline gavage in 24 Sprague-Dawley rats. A further six rats were included as a Control group. The constipated rats were divided into four groups (n=6 each): a Constipation group that remained untreated; a Constipation+LI11 group that received EA at LI11; a Constipation+ST37 groups that received EA at ST37; and a Constipation+LI11+ST37 group that received EA at both LI11 and ST37. After EA treatment, faecal water content, defaecation frequency, and gastrointestinal (GI) transit were measured, as well as the expression of tryptophan hydroxylase (TPH) in colonic tissues (by Western blot analysis) and 5-HT in both faeces and colonic tissues (by ELISA). Results All three EA-treated groups demonstrated significant improvements in faecal water content, defaecation frequency and GI transit (pConclusions EA at LI11 and/or ST37 had a positive effect on objective markers of constipation in a rat model. In addition, EA increased 5-HT and TPH in the colonic tissues.
- 12 May 2016
- Published by Wiley in Journal of Molecular Recognition
- Vol. 29 (10) , 485-491
Novel biosensor system model based on fluorescence quenching by a fluorescent streptavidin and carbazole-labeled biotin
In the present study, a novel molecular biosensor system model was designed by using a couple of the fluorescent unnatural mutant streptavidin and the carbazole-labeled biotin. BODIPY-FL-aminophenylalanine (BFLAF), a fluorescent unnatural amino acid was position-specifically incorporated into Trp120 position of streptavidin by four-base codon method. On the other hand, carbazole-labeled biotin was synthesized as a quencher for the fluorescent Trp120BFLAF mutant streptavidin. The fluorescence of fluorescent Trp120BFLAF mutant streptavidin was decreased as we expected when carbazole-labeled biotin was added into the mutant streptavidin solution. Furthermore, the fluorescence decrease of Trp120BFLAF mutant streptavidin with carbazole-labeled biotin (100 nM) was recovered by the competitive addition of natural biotin. This result demonstrated that by measuring the fluorescence quenching and recovery, a couple of the fluorescent Trp120BFLAF mutant streptavidin and the carbazole-labeled biotin were successfully applicable for quantification of free biotin as a molecular biosensor system. Copyright © 2016 John Wiley & Sons, Ltd.
- 12 May 2016
- Published by Wiley in Journal of Molecular Recognition
- Vol. 29 (10) , 485-491
Novel biosensor system model based on fluorescence quenching by a fluorescent streptavidin and carbazole-labeled biotin
In the present study, a novel molecular biosensor system model was designed by using a couple of the fluorescent unnatural mutant streptavidin and the carbazole-labeled biotin. BODIPY-FL-aminophenylalanine (BFLAF), a fluorescent unnatural amino acid was position-specifically incorporated into Trp120 position of streptavidin by four-base codon method. On the other hand, carbazole-labeled biotin was synthesized as a quencher for the fluorescent Trp120BFLAF mutant streptavidin. The fluorescence of fluorescent Trp120BFLAF mutant streptavidin was decreased as we expected when carbazole-labeled biotin was added into the mutant streptavidin solution. Furthermore, the fluorescence decrease of Trp120BFLAF mutant streptavidin with carbazole-labeled biotin (100 nM) was recovered by the competitive addition of natural biotin. This result demonstrated that by measuring the fluorescence quenching and recovery, a couple of the fluorescent Trp120BFLAF mutant streptavidin and the carbazole-labeled biotin were successfully applicable for quantification of free biotin as a molecular biosensor system. Copyright © 2016 John Wiley & Sons, Ltd.
- 23 October 2015
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (23) , 9957-9962
A novel molecular biosensor system model designed by using a couple composed of a fluorescent mutant binding protein and fluorophore-labeled ligand analogue based on the FRET mechanism
The design of a novel molecular biosensor system model using Trp120BFLAF mutant streptavidin and Alexa546-biotin based on the FRET mechanism.
- 23 October 2015
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (23) , 9957-9962
A novel molecular biosensor system model designed by using a couple composed of a fluorescent mutant binding protein and fluorophore-labeled ligand analogue based on the FRET mechanism
The design of a novel molecular biosensor system model using Trp120BFLAF mutant streptavidin and Alexa546-biotin based on the FRET mechanism.
- Open Access
- 20 March 2014
- Published by Wiley in The Scientific World Journal
- Vol. 2014, 1-6
Fluorescence Enhancement of Fluorescent Unnatural Streptavidin by Binding of a Biotin Analogue with Spacer Tail and Its Application to Biotin Sensing
We designed a novel molecular biosensing system for the detection of biotin, an important vitamin by the combination of fluorescent unnatural streptavidin with a commercialized biotin-(AC5)2-hydrazide. A fluorescent unnatural amino acid, BODIPY-FL-aminophenylalanine (BFLAF), was position-specifically incorporated into Trp120 of streptavidin by four-base codon method. Fluorescence of the Trp120BFLAF mutant streptavidin was enhanced by the addition of biotin-(AC5)2-hydrazide with the concentration dependent, whereas fluorescence enhancement was not observed at all by the addition of natural biotin. It was considered that the spacer tail of biotin-(AC5)2-hydrazide may disturb the fluorescence quenching of the Trp120BFLAF by Trp79 and Trp108 of the neighbor subunit. Therefore, biotin sensing was carried out by the competitive binding reaction of biotin-(AC5)2-hydrazide and natural biotin to the fluorescent mutant streptavidin. The fluorescence intensity decreased by increasing free biotin concentration. The result suggested that molecular biosensor for small ligand could be successfully designed by the pair of fluorescent mutant binding protein and ligand analogue.
- 20 March 2014
- Published by Wiley in The Scientific World Journal
- Vol. 2014, 1-6
Open AccessFluorescence Enhancement of Fluorescent Unnatural Streptavidin by Binding of a Biotin Analogue with Spacer Tail and Its Application to Biotin Sensing
We designed a novel molecular biosensing system for the detection of biotin, an important vitamin by the combination of fluorescent unnatural streptavidin with a commercialized biotin-(AC5)2-hydrazide. A fluorescent unnatural amino acid, BODIPY-FL-aminophenylalanine (BFLAF), was position-specifically incorporated into Trp120 of streptavidin by four-base codon method. Fluorescence of the Trp120BFLAF mutant streptavidin was enhanced by the addition of biotin-(AC5)2-hydrazide with the concentration dependent, whereas fluorescence enhancement was not observed at all by the addition of natural biotin. It was considered that the spacer tail of biotin-(AC5)2-hydrazide may disturb the fluorescence quenching of the Trp120BFLAF by Trp79 and Trp108 of the neighbor subunit. Therefore, biotin sensing was carried out by the competitive binding reaction of biotin-(AC5)2-hydrazide and natural biotin to the fluorescent mutant streptavidin. The fluorescence intensity decreased by increasing free biotin concentration. The result suggested that molecular biosensor for small ligand could be successfully designed by the pair of fluorescent mutant binding protein and ligand analogue.